Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Berciano-Guerrero MA"'
Autor:
Miguel Ángel Berciano Guerrero, Maciej Rybinski, Esteban López-Camacho, José García-Nieto, José F. Aldana-Montes, Rocio Lavado, Ismael Navas-Delgado
Publikováno v:
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
BMC Bioinformatics, Vol 20, Iss S4, Pp 1-11 (2019)
BMC Bioinformatics
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Universidad de Sevilla (US)
BMC Bioinformatics, Vol 20, Iss S4, Pp 1-11 (2019)
BMC Bioinformatics
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Background: The analysis of gene expression levels is used in many clinical studies to know how patients evolve or to find new genetic biomarkers that could help in clinical decision making. However, the techniques and software available for these an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33917cbd838079f31d38f2e1cbc708d6
Autor:
Cerezuela-Fuentes P; Oncology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Ciudad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Gonzalez-Cao M; Translational Cancer Research Unit, Dr. Rosell Oncology Institute (IOR), Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain. mgonzalezcao@oncorosell.com., Puertolas T; Oncology Department, Hospital Miguel Servet, Saragossa, Spain., Manzano JL; Catalan Institute of Oncology (ICO-Badalona), Hospital Germans Trias i Pujol, Badalona, Spain., Maldonado C; Dermatology Department, Hospital Universitario de Asturias, Oviedo, Spain., Yelamos O; Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Berciano-Guerrero MA; Oncology Department Hospitales, Universitarios Regional y Virgen de la Victoria (HURyVV), Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Málaga, Spain., Martin-Liberal J; Catalan Institute of Oncology (ICO-Hospitalet), Hospital Duran i Reynals, Barcelona, Spain., Muñoz-Couselo E; Oncology Department, Hospital Valle Hebron, Barcelona, Spain., Espinosa E; Oncology Department, Hospital Universitario la Paz, Madrid, Spain.; CIBERER, Barcelona, Spain., Drozdowskyj A; Oncology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Ciudad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Berrocal A; Oncology Department, Hospital General de Valencia, Valencia, Spain., Soria A; Oncology Department, Hospital Ramon y Cajal, Madrid, Spain., Marquez-Rodas I; Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain., Martin-Algarra S; Oncology Department, Clinica Universidad de Navarra, Pamplona, Spain., Quindos M; Medical Oncology Department, Complexo Hospitalario Universitario de A Coruña. Biomedical Research Institute (INIBIC), A Coruña, Spain., Puig S; CIBERER, Barcelona, Spain. spuig@clinic.cat.; Dermatology Department, Hospital Clinic Barcelona, University of Barcelona, IDIBAPS, C Villrroel, 08023, Barcelona, Spain. spuig@clinic.cat.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jul 01. Date of Electronic Publication: 2024 Jul 01.
Autor:
Clingan P; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia., Ladwa R; Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia., Brungs D; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia.; Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia., Harris DL; Christchurch Hospital, Christchurch, New Zealand., McGrath M; Medical Oncology, Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia., Arnold S; Exellentis Clinical Trial Consultants, George, South Africa., Coward J; ICON Cancer Centre, South Brisbane, Queensland, Australia., Fourie S; Wilgers Oncology Centre, Pretoria, South Africa., Kurochkin A; Municipal Nonprofit Enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Dispensary, Sumy, Ukraine., Malan DR; Phoenix Pharma, Port Elizabeth, South Africa., Mant A; Medical Oncology Unit, Eastern Health, Melbourne, Victoria, Australia., Sharma V; Wits Clinical Research Chris Hani Baragwanath Clinical Trial Site, Johannesburg, South Africa., Shue H; Sunshine Coast Haematology and Oncology Clinic, Buderim, Queensland, Australia., Tazbirkova A; Medical Oncology, Pindara Private Hospital, Gold Coast, Queensland, Australia., Berciano-Guerrero MA; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Charoentum C; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand., Dalle S; Hospices Civils de Lyon - Hopital Lyon Sud, Pierre-Bénite, France., Dechaphunkul A; Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand., Dudnichenko O; Kharkiv Medical Academy of Postgraduate Education, Chair of Oncology and Children's Oncology, Clinical base State institution 'VT Zaycev Institute of General and Urgent Surgery of National Academy Medical Sciences of Ukraine', Kharkiv, Ukraine., Koralewski P; Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o., Oddział Onkologii Klinicznej z Pododdziałem Dziennym, Kraków, Poland., Lugowska I; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Oddział Badań Wczesnych Faz, Warsaw, Poland., Montaudié H; Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, France., Muñoz-Couselo E; Hospital Universitario Vall d'Hebron, Passeig de la Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Sriuranpong V; King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Oliviero J; Checkpoint Therapeutics Inc, Waltham, Massachusetts, USA jfo@checkpointtx.com., Desai J; Department of Medical Oncology, Peter MacCallum Cancer Centre; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Oct; Vol. 11 (10).
Autor:
Guardamagna M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Department of Medicine and Dermatology, Medical School University of Málaga, Campus Teatinos, Blvr. Louis Pasteur, 32, 29010 Málaga, Spain., Berciano-Guerrero MA; Department of Medicine and Dermatology, Medical School University of Málaga, Campus Teatinos, Blvr. Louis Pasteur, 32, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Group of Translational Research in Cancer Immunotherapy, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Villaescusa-González B; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Perez-Ruiz E; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Group of Translational Research in Cancer Immunotherapy, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Oliver J; Medical Oncology Intercenter Unit, Group of Translational Research in Cancer Immunotherapy, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Lavado-Valenzuela R; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Rueda-Dominguez A; Department of Medicine and Dermatology, Medical School University of Málaga, Campus Teatinos, Blvr. Louis Pasteur, 32, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Group of Translational Research in Cancer Immunotherapy, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Barragán I; Medical Oncology Intercenter Unit, Group of Translational Research in Cancer Immunotherapy, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Group of Pharmacoepigenetics, Department of Physiology and Pharmacology, Karolinska Institute, Tomtebodavägen 16, 171 65 Solna, Sweden., Queipo-Ortuño MI; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Department of Surgical Specialties, Biochemical and Immunology, Faculty of Medicine, University of Málaga, 29071 Málaga, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 09; Vol. 23 (19). Date of Electronic Publication: 2022 Oct 09.
Autor:
Berciano-Guerrero MA; Medical Oncology Intercenter Unit (Group of Translational Research in Cancer Immunotherapy), Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Department of Medicine and Dermatology, Medical School University of Málaga, Campus Teatinos, Blvr. Louis Pasteur, 32, 29010 Málaga, Spain., Guardamagna M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Department of Medicine and Dermatology, Medical School University of Málaga, Campus Teatinos, Blvr. Louis Pasteur, 32, 29010 Málaga, Spain., Perez-Ruiz E; Medical Oncology Intercenter Unit (Group of Translational Research in Cancer Immunotherapy), Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Jurado JM; Medical Oncology Intercenter Unit (Group of Translational Research in Cancer Immunotherapy), Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Barragán I; Medical Oncology Intercenter Unit (Group of Translational Research in Cancer Immunotherapy), Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Group of Pharmacoepigenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden., Rueda-Dominguez A; Medical Oncology Intercenter Unit (Group of Translational Research in Cancer Immunotherapy), Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; Department of Medicine and Dermatology, Medical School University of Málaga, Campus Teatinos, Blvr. Louis Pasteur, 32, 29010 Málaga, Spain.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2022 Aug 24; Vol. 12 (9). Date of Electronic Publication: 2022 Aug 24.
Autor:
Berciano-Guerrero MA; Medical Oncology, IBIMA, Medical Oncology Intercenter Unit, Hospital Regional Universitario de Malaga, Regional and Virgen de la Victoria University Hospitals, 29010 Málaga, Spain.; Clinical and Translational Cancer Research Group, IBIMA, 29010 Málaga, Spain., Lavado-Valenzuela R; Clinical and Translational Cancer Research Group, IBIMA, 29010 Málaga, Spain.; Cancer Molecular Biology Lab, 29010 Málaga, Spain., Moya A; Cancer Molecular Biology Lab, 29010 Málaga, Spain.; Medicine School, University of Málaga, 29010 Málaga, Spain., delaCruz-Merino L; Medical Oncology, Virgen Macarena University Hospital, 41009 Seville, Spain., Toscano F; Medical Oncology, Hospital Juan Ramon Jimenez, 21005 Huelva, Spain., Valdivia J; Service of Medical Oncology, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain., Castellón V; Medical Oncology, Complejo Hospitalario Torrecardenas, 04009 Almería, Spain., Henao-Carrasco F; Medical Oncology, Virgen Macarena University Hospital, 41009 Seville, Spain., Sancho P; Medical Oncology, Hospital Universitario Virgen del Rocio, 41013 Seville, Spain., Onieva-Zafra JL; Medical Oncology, IBIMA, Medical Oncology Intercenter Unit, Hospital Regional Universitario de Malaga, Regional and Virgen de la Victoria University Hospitals, 29010 Málaga, Spain.; Medicine School, University of Málaga, 29010 Málaga, Spain., Navas-Delgado I; Khaos Research, University of Malaga, 29010 Málaga, Spain., Rueda-Dominguez A; Medical Oncology, IBIMA, Medical Oncology Intercenter Unit, Hospital Regional Universitario de Malaga, Regional and Virgen de la Victoria University Hospitals, 29010 Málaga, Spain., Perez-Ruiz E; Medical Oncology, IBIMA, Medical Oncology Intercenter Unit, Hospital Regional Universitario de Malaga, Regional and Virgen de la Victoria University Hospitals, 29010 Málaga, Spain., Alba E; Medical Oncology, IBIMA, Medical Oncology Intercenter Unit, Hospital Regional Universitario de Malaga, Regional and Virgen de la Victoria University Hospitals, 29010 Málaga, Spain.; Clinical and Translational Cancer Research Group, IBIMA, 29010 Málaga, Spain.; Cancer Molecular Biology Lab, 29010 Málaga, Spain.; Medicine School, University of Málaga, 29010 Málaga, Spain.
Publikováno v:
Biomedicines [Biomedicines] 2022 Jan 26; Vol. 10 (2). Date of Electronic Publication: 2022 Jan 26.
Autor:
Gonzalez-Cao M; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain. mgonzalezcao@oncorosell.com., Mayo de Las Casas C; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Oramas J; Hospital Universitario de Canarias, Tenerife, Spain., Berciano-Guerrero MA; Hospitales Universitarios Regional y Virgen de la Victoria (HURyVV). Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Málaga, Spain., de la Cruz L; Hospital Universitario Virgen Macarena, Sevilla, Spain., Cerezuela P; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Arance A; Hospital Clinic, Barcelona, Spain., Muñoz-Couselo E; Hospital Valle Hebron, Barcelona, Spain., Espinosa E; Hospital Universitario la Paz, CIBERONC, Madrid, Spain., Puertolas T; Hospital Miguel Servet, Zaragoza, Spain., Diaz Beveridge R; Hospital Universitario la Fe, Valencia, Spain., Ochenduszko S; Hospital Universitario Dr Peset, Valencia, Spain., Villanueva MJ; Hospital de Vigo, Pontevedra, Spain., Basterretxea L; Hospital Universitario de Donostia, Guipuzkoa, Spain., Bellido L; Hospital Universitario de Salamanca, Salamanca, Spain., Rodriguez D; Hospital Insular Las Palmas, Las Palmas de Gran Canaria, Spain., Campos B; Hospital Lucus Agusti, Lugo, Spain., Montagut C; Hospital del Mar, IMIM, CIBERONC, Barcelona, Spain., Drozdowskyj A; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Molina MA; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Lopez-Martin JA; Hospital 12 de Octubre, Madrid, Spain., Berrocal A; Hospital General de Valencia, Valencia, Spain. berrocal.alf@gmail.com.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 01; Vol. 12 (1), pp. 7008. Date of Electronic Publication: 2021 Dec 01.
Autor:
Salas M; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain., Berciano-Guerrero MA; Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain., Palomares F; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain., Rueda A; Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain., Fernandez TD; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain., Mayorga C; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Centro Andaluz de Nanomedicina y Biotecnología-BIONAND, Málaga, Spain., Torres MJ; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Centro Andaluz de Nanomedicina y Biotecnología-BIONAND, Málaga, Spain.; Medicine Department, Universidad de Málaga-UMA, Málaga, Spain.
Publikováno v:
Allergy [Allergy] 2021 Jul; Vol. 76 (7), pp. 2285-2288. Date of Electronic Publication: 2021 Mar 24.
Autor:
Pérez-Ruiz E; Oncology Department, Hospital Costa del Sol, Autovía A-7, Km 187, C.P. 29603, Marbella, Málaga, Spain. eliperu@gmail.com., Jiménez-Castro J; Oncology Department, Hospital Virgen del Rocío, Seville, Spain., Berciano-Guerrero MA; Interinstitutional Oncology Unit, Institute of Biomedical Research in Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria (HURyVV), Malaga, Spain., Valdivia J; Oncology Department, Hospital Virgen de las Nieves, Granada, Spain., Estalella-Mendoza S; Oncology Department, Hospital Puerta del Mar, Cádiz, Spain., Toscano F; Oncology Department, Hospital Juan Ramón Jiménez, Huelva, Spain., Rodriguez de la Borbolla Artacho M; Oncology Department, Hospital de Valme, Seville, Spain., Garrido-Siles M; Pharmacy Department, Hospital Costa del Sol, Marbella, Spain., Martínez-Bautista MJ; Pharmacy Department, Hospital Puerta del Mar, Cádiz, Spain., Villatoro Roldan R; Oncology Department, Hospital Costa del Sol, Autovía A-7, Km 187, C.P. 29603, Marbella, Málaga, Spain., Rivas-Ruiz F; Research Support Unit, Hospital Costa del Sol, Marbella, Spain., Nogales-Fernández E; Oncology Department, Hospital Virgen Macarena, Seville, Spain., Morales C; Oncology Department, Hospital Reina Sofía, Córdoba, Spain., Pérez-Valderrama B; Oncology Department, Hospital Virgen del Rocío, Seville, Spain., De la Cruz-Merino L; Oncology Department, Hospital Virgen Macarena, Seville, Spain., Rueda A; Interinstitutional Oncology Unit, Institute of Biomedical Research in Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria (HURyVV), Malaga, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2020 Oct; Vol. 22 (10), pp. 1778-1785. Date of Electronic Publication: 2020 Feb 24.
Autor:
Alba-Linero C; Ophthalmology Department, Hospital Regional Málaga, Plaza del Hospital Civil, Málaga, Spain., Rocha De Lossada C; Ophthalmology Department, Hospital Regional Málaga, Plaza del Hospital Civil, Málaga, Spain., Delgado-Fernández AS; Ophthalmology Department, Hospital Regional Málaga, Plaza del Hospital Civil, Málaga, Spain., Jódar-Márquez M; Ophthalmology Department, Hospital Regional Málaga, Plaza del Hospital Civil, Málaga, Spain., Rodríguez Calvo De Mora M; Ophthalmology Department, Hospital Regional Málaga, Plaza del Hospital Civil, Málaga, Spain., Berciano-Guerrero MA; Oncology Department. Hospital Regional Málaga, Málaga, Spain.
Publikováno v:
Journal of biological regulators and homeostatic agents [J Biol Regul Homeost Agents] 2019 September-October,; Vol. 33 (5), pp. 1497-1500.